Literature DB >> 23070605

Advances in oncologic imaging: update on 5 common cancers.

Oguz Akin1, Sandra B Brennan, D David Dershaw, Michelle S Ginsberg, Marc J Gollub, Heiko Schöder, David M Panicek, Hedvig Hricak.   

Abstract

Imaging has become a pivotal component throughout a patient's encounter with cancer, from initial disease detection and characterization through treatment response assessment and posttreatment follow-up. Recent progress in imaging technology has presented new opportunities for improving clinical care. This article provides updates on the latest approaches to imaging of 5 common cancers: breast, lung, prostate, and colorectal cancers, and lymphoma.
Copyright © 2012 American Cancer Society, Inc.

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 23070605     DOI： 10.3322/caac.21156

Source DB:  PubMed          Journal:  CA Cancer J Clin        ISSN： 0007-9235            Impact factor:   508.702


  20 in total

1.  An eight-year prospective controlled study about the safety and diagnostic value of cardiac and non-cardiac 1.5-T MRI in patients with a conventional pacemaker or a conventional implantable cardioverter defibrillator.

Authors:  Pierpaolo Lupo; Riccardo Cappato; Giovanni Di Leo; Francesco Secchi; Giacomo D E Papini; Sara Foresti; Hussam Ali; Guido M G De Ambroggi; Antonio Sorgente; Gianluca Epicoco; Paola M Cannaò; Francesco Sardanelli
Journal:  Eur Radiol       Date:  2018-01-09       Impact factor: 5.315

2.  Automatic classification of ultrasound breast lesions using a deep convolutional neural network mimicking human decision-making.

Authors:  Alexander Ciritsis; Cristina Rossi; Matthias Eberhard; Magda Marcon; Anton S Becker; Andreas Boss
Journal:  Eur Radiol       Date:  2019-03-29       Impact factor: 5.315

3.  In vitro and in vivo anti-tumour effects of MPT0B014, a novel derivative aroylquinoline, and in combination with erlotinib in human non-small-cell lung cancer cells.

Authors:  An-Chi Tsai; Hui-Chen Pai; Chih-Ya Wang; Jing-Ping Liou; Che-Ming Teng; Jing-Chi Wang; Shiow-Lin Pan
Journal:  Br J Pharmacol       Date:  2014-01       Impact factor: 8.739

Review 4.  Image-derived biomarkers and multimodal imaging strategies for lung cancer management.

Authors:  Alexander W Sauter; Nina Schwenzer; Mathew R Divine; Bernd J Pichler; Christina Pfannenberg
Journal:  Eur J Nucl Med Mol Imaging       Date:  2015-01-09       Impact factor: 9.236

5.  High expression of MAGE-A9 in tumor and stromal cells of non-small cell lung cancer was correlated with patient poor survival.

Authors:  Siya Zhang; Xiaolu Zhai; Gui Wang; Jian Feng; Huijun Zhu; Liqin Xu; Guoxin Mao; Jianfei Huang
Journal:  Int J Clin Exp Pathol       Date:  2015-01-01

Review 6.  Associations of CYP2E1 rs2031920 and rs3813867 polymorphisms with colorectal cancer risk: a systemic review and meta-analysis.

Authors:  Hui Peng; Shang-Kui Xie; Mei-Jin Huang; Dong-Lin Ren
Journal:  Tumour Biol       Date:  2013-04-18

7.  Overexpression of BIRC6 Is a Predictor of Prognosis for Colorectal Cancer.

Authors:  Tingting Hu; Shuqiang Weng; Wenqing Tang; Ruyi Xue; She Chen; Guoxiang Cai; Yu Cai; Xizhong Shen; Si Zhang; Ling Dong
Journal:  PLoS One       Date:  2015-05-01       Impact factor: 3.240

8.  Ultrasound-triggered phase transition sensitive magnetic fluorescent nanodroplets as a multimodal imaging contrast agent in rat and mouse model.

Authors:  Xin Cheng; Huan Li; Yunchao Chen; Binhua Luo; Xuhan Liu; Wei Liu; Haibo Xu; Xiangliang Yang
Journal:  PLoS One       Date:  2013-12-31       Impact factor: 3.240

9.  Meta-analysis of the association between COX-2 polymorphisms and risk of colorectal cancer based on case-control studies.

Authors:  Qiliu Peng; Shi Yang; Xianjun Lao; Weizhong Tang; Zhiping Chen; Hao Lai; Jian Wang; Jingzhe Sui; Xue Qin; Shan Li
Journal:  PLoS One       Date:  2014-04-14       Impact factor: 3.240

10.  Novel Methylated DNA Markers in the Surveillance of Colorectal Cancer Recurrence.

Authors:  Hao Xie; Douglas W Mahoney; Patrick H Foote; Kelli N Burger; Karen A Doering; William R Taylor; Sara S Then; Xiaoming Cao; Maria McGlinch; Calise K Berger; Tsung-Teh Wu; Joleen M Hubbard; Hatim T Allawi; Michael W Kaiser; Graham P Lidgard; David A Ahlquist; John B Kisiel
Journal:  Clin Cancer Res       Date:  2020-10-07       Impact factor: 13.801
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.